Alnylam Pharmace. buy daimler1
Start price
26.02.23
/
50%
€182.32
Target price
26.02.24
-
Performance (%)
2.35%
End price
02.04.23
€186.60
Summary
This prediction ended on 02.04.23 with a price of €186.60. With a performance of 2.35%, the BUY prediction by daimler1 for Alnylam Pharmace. closed with a slight gain. daimler1 has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
AI-generated
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Alnylam Pharmace. | -0.279% | -0.279% | -50.089% | 14.720% |
| iShares Core DAX® | -1.586% | 5.028% | 6.332% | 64.061% |
| iShares Nasdaq 100 | -4.148% | -0.125% | 25.735% | 86.918% |
| iShares Nikkei 225® | -6.302% | 0.528% | 41.384% | 77.872% |
| iShares S&P 500 | -3.225% | 0.470% | 20.449% | 68.192% |
Comments by daimler1 for this prediction
In the thread Alnylam Pharmace. diskutieren
Buy Alnylam Pharmace.